Cyclerion (CYCN) - Yalpi foyda koeffitsiyenti

CYCN (Cyclerion Therapeutics) - kompaniyaning tovar belgisi

Cyclerion Therapeutics (CYCN) kompaniyasining investitsiya potentsiali ilmiy sherikliklar orqali kamyob markaziy nerv tizimi va buyrak patologiyalari uchun dori vositalarini ishlab chiqishga asoslangan. Yalpi daromad ko'rsatkichi ushbu samaradorlikni vizuallashtiradi, bunda 0.00 joriy parametr qiymati vazifasini bajaradi. O'sish sGC stimulyatorlari uchun B2B litsenziyalashning kengayishi, shuningdek, aksiyalar opsion tizimi va maqsadli rekruting orqali jalb qilingan kuchli neyrobiologlar shtatining saqlab qolinishi bilan tasdiqlanadi.

CYCN (cyclerion.com) Yalpi marja tarixi 04.07.2022dan 09.09.2026gacha

Cyclerion Therapeutics, Inc. (CYCN) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor kapitallashuvi ko'rsatkichlari:
- pul mablag'lari va pul oqimlari statistikasi:
Kompaniyaning asosiy tahlili:Cyclerion Therapeutics CYCN
cyclerion.com tomonidan chiqariladigan mahsulotlar

Fundamental tahlil operatsion xarajatlarning ortishi fonida biznesning barqarorligini stress-testdan o'tkazishni talab qiladi. Cyclerion Therapeutics (CYCN) eksklyuziv molekulalarning yuqori bozor qiymatiga tayanib, kognitiv buzilishlar terapiyasi uchun noyob stimulyatorlarni ishlab chiqmoqda. Median yalpi foyda marjasining tahlili sotilgan tovarlar tannarxini chegirib tashlagandan keyingi foyda ulushini baholash imkonini beradi, bunda ushbu ko'rsatkichning barqaror o'sishi monopol narx belgilash imkoniyati va intellektual mulk kapitalizatsiyasining yuqori samaradorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)